One-third of Alzheimer’s patients using approved drug see brain swelling: study

Researchers found brain swelling in 35% of Alzheimer’s disease patients using aducanumab, a drug treatment newly approved by the Food and Drug Administration.

A study published Monday in the medical journal JAMA Neurology reported that 362 of 1,029 patients with Alzheimer’s disease who received the drug experienced brain inflammation in …


Please follow and like us: